JP2014113118A - Three-dimensional cultured tissue that perfuses culture medium to support layer containing cell - Google Patents

Three-dimensional cultured tissue that perfuses culture medium to support layer containing cell Download PDF

Info

Publication number
JP2014113118A
JP2014113118A JP2012270959A JP2012270959A JP2014113118A JP 2014113118 A JP2014113118 A JP 2014113118A JP 2012270959 A JP2012270959 A JP 2012270959A JP 2012270959 A JP2012270959 A JP 2012270959A JP 2014113118 A JP2014113118 A JP 2014113118A
Authority
JP
Japan
Prior art keywords
culture
cells
dimensional
dimensional cultured
cultured tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012270959A
Other languages
Japanese (ja)
Other versions
JP6047000B2 (en
Inventor
Katsutoshi Yoshizato
勝利 吉里
Daisuke Tsuruta
大輔 鶴田
Noribumi Kawada
則文 河田
Miho Shimada
美穂 島田
Natsumi Saito
夏美 齋藤
Hiroshi Tanaka
浩 田中
Takeshi Ofusa
健 大房
Mutsumi Inamatsu
睦 稲松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osaka University NUC
Nippon Menard Cosmetic Co Ltd
Osaka City University
Original Assignee
Osaka University NUC
Nippon Menard Cosmetic Co Ltd
Osaka City University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osaka University NUC, Nippon Menard Cosmetic Co Ltd, Osaka City University filed Critical Osaka University NUC
Priority to JP2012270959A priority Critical patent/JP6047000B2/en
Publication of JP2014113118A publication Critical patent/JP2014113118A/en
Application granted granted Critical
Publication of JP6047000B2 publication Critical patent/JP6047000B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide in vitro three-dimensional cultured tissue having more resembled status to in vivo tissue.SOLUTION: Three-dimensional cultured tissue in culture medium perfusion method is produced, as it is found that cells can be cultured in imitation of body fluid circulation environment by: adding tensile force to cells like a living body by inhibiting shrinkage in the horizontal direction of a supporting layer containing the cells; and supplying a fresh culture medium always in a constant flow rate. In the three-dimensional cultured tissue, it becomes possible to maintain cells for a prolonged period in a more resembled status to in vivo tissue.

Description

本発明は、生体内に類似した3次元培養組織に関し、更に詳しくは、細胞を含む支持体層に培養液を灌流させることを特徴とする3次元培養組織に関する。   The present invention relates to a three-dimensional cultured tissue similar to that in a living body, and more particularly to a three-dimensional cultured tissue characterized by perfusing a culture solution to a support layer containing cells.

ヒト細胞を体から分離して人工環境(インビトロ)で培養することによってその細胞の体の中(インビボ)での性質を科学的に調査する方法として、細胞培養法は有用な技術であり、研究者の間で広く利用されて来た。代表的な方法は2次元的広がりを持つプラスチック培養皿の表面に培養する方法で平面培養と呼ばれる。この技術は多くの変法があるが基本技術は公知である。   Cell culture is a useful technique as a method for scientifically investigating the properties of human cells in the body (in vivo) by separating them from the body and culturing them in an artificial environment (in vitro). It has been widely used among those. A typical method is a method of culturing on the surface of a plastic culture dish having a two-dimensional spread and is called flat culture. There are many variations of this technique, but the basic technique is known.

平面培養に比べて、3次元的広がりを持つ支持体(細胞の足場、マトリックス)の中で培養する方法を立体培養と呼ぶ。立体培養は平面培養に比べてよりインビボに近い環境を細胞に与え、この様に培養された細胞を含む支持体は3次元培養組織と呼ばれる。立体培養法にも多くの変法(特許文献1〜2、非特許文献1〜3)がある。流布している多くの立体培養はその培養液を必要に応じて新鮮な培養液で置換させるものであり、静置立体培養と呼ぶ。   A method of culturing in a support (cell scaffold, matrix) having a three-dimensional extent as compared to planar culture is called three-dimensional culture. Three-dimensional culture gives cells a more in vivo environment than planar culture, and a support containing cells cultured in this way is called a three-dimensional cultured tissue. There are many variations of the three-dimensional culture method (Patent Documents 1 and 2, Non-Patent Documents 1 to 3). Many of the three-dimensional cultures that have been disseminated replace the culture medium with a fresh culture medium as necessary, and are called stationary three-dimensional culture.

3次元培養組織は、医薬品や化粧品の安全性評価、有効性評価に有用な生体のモデルであり、近年、動物愛護の観点から動物実験の代替としてもその利用が広がっている。   A three-dimensional cultured tissue is a model of a living body useful for safety evaluation and effectiveness evaluation of pharmaceuticals and cosmetics. In recent years, its use has expanded as an alternative to animal experiments from the viewpoint of animal welfare.

特開2009−112277JP2009-112277A 特表2008−519598Special table 2008-519598

Yoshizato K et al,BiomedicalRes,6:287−296,1985.Yoshizato K et al, Biomedical Res, 6: 287-296, 1985. Kawada N et al,Biochem BiophysRes Commun,266(2):296−300,1999.Kawada N et al, Biochem Biophys Res Commun, 266 (2): 296-300, 1999. Hu T et al,Toxicol In Vitro,24(5):1450−1463,2010.Hu T et al, Toxicol In Vitro, 24 (5): 1450-1463, 2010.

本発明は、生体内により近い状態の3次元培養組織を提供することを課題とする。   An object of the present invention is to provide a three-dimensional cultured tissue that is closer to the living body.

生体に近似の3次元培養組織の培養法として「コラーゲンゲル培養法」がある。この方法は、細胞を水和化したゲル状のコラーゲン線維格子内に3次元的に封入して培養するものであるが、インビボの状態を正確に反映できないという基本的問題が存在していた。1つはゲル内部に酸素や栄養素が十分浸透しないために細胞が壊死化する問題、他の1つは、ゲルが収縮して体積を減じ、生体内では見られない凝集体化することである。生体内組織は張力付加状態にあり、かつ血管が隅々まで発達していることにより、この様な問題は起きていない。   There is a “collagen gel culture method” as a method of culturing a three-dimensional cultured tissue approximate to a living body. Although this method is one in which cells are three-dimensionally enclosed in a hydrated gel-like collagen fiber lattice and cultured, there has been a basic problem that the in vivo state cannot be accurately reflected. One is the problem of cell necrosis due to insufficient penetration of oxygen and nutrients inside the gel, and the other is that the gel shrinks to reduce volume and aggregates that are not seen in the body. . Such a problem does not occur because the tissue in the living body is in a tensioned state and the blood vessel has developed to every corner.

さらに、生体の細胞は、単独でその機能を果たしているのではなく,直接的或いは間接的に近隣或いは遠隔地の細胞の影響を受けながらその機能を発揮できる。このような体内における細胞間のネットワークは、体液循環に依存するところが大きいが、インビトロ培養法による3次元培養組織は細胞間のネットワークを除去した組織であって、当該細胞のインビボ機能を再現出来ていない。   Furthermore, living cells do not perform their functions alone, but can perform their functions while being directly or indirectly influenced by neighboring or remote cells. Such a network between cells in the body largely depends on the body fluid circulation, but the three-dimensional culture tissue by in vitro culture method is a tissue from which the network between cells is removed, and the in vivo function of the cell can be reproduced. Absent.

また、これまでの培養法では、3次元培養組織の培養可能期間は10日程であり、それ以上に長期間培養すると細胞機能が低下或いは細胞死してしまう。そこで、生体に類似の細胞機能を長期間維持するための細胞培養デバイス(特許文献2)が開示されているが、培養液の供給がデバイスのチャネル(溝)を流れる液からの拡散によること、細胞が複数の突起によって確定されるチャンバに保持されており、細胞外マトリックスとの相互作用により、生体と同じような張力が負荷されないことなど、インビボの状態との違いがある。したがって、長期間培養可能で、且つインビボの状態により類似した細胞を含む3次元培養組織の開発が求められている。   In the conventional culture method, the cultivatable period of the three-dimensional cultured tissue is about 10 days, and if the culture is performed for a longer period than that, the cell function is lowered or the cell is killed. Therefore, a cell culture device (Patent Document 2) for maintaining a cell function similar to that of a living body for a long period of time is disclosed, but the supply of the culture solution is due to diffusion from the liquid flowing in the channel (groove) of the device, There are differences from the in vivo state in that cells are held in a chamber defined by a plurality of protrusions, and the same tension as that of a living body is not applied due to the interaction with the extracellular matrix. Accordingly, there is a need for the development of a three-dimensional cultured tissue that can be cultured for a long period of time and contains cells that are more similar to the in vivo state.

生体の細胞は体液循環系の中に取り込まれており、絶えず流体力学的影響と栄養素/酸素の供給を受けている。また、細胞外マトリックスとの相互作用により張力が付加されている。本発明者等は、鋭意検討を重ねた結果、細胞を含む支持体の水平方向の収縮を阻害することで細胞に生体と同じように張力を付加するとともに常時一定の流速で新鮮な培養液を供給することにより、体液循環環境に似せて細胞を培養できることを発見し、本発明を完成するに至った。   Living cells are entrained in the circulatory system and are constantly receiving hydrodynamic effects and nutrient / oxygen supplies. In addition, tension is applied by interaction with the extracellular matrix. As a result of intensive studies, the present inventors added a tension to the cells in the same manner as the living body by inhibiting the horizontal contraction of the support containing the cells, and constantly added a fresh culture solution at a constant flow rate. By supplying, it was discovered that cells can be cultured to resemble a body fluid circulation environment, and the present invention has been completed.

すなわち、本発明は、
[1]細胞を含む支持体層に培養液を灌流させ製造することを特徴とする3次元培養組織。
[2]培養液の灌流が、培養液を支持体に挿入したチューブを通じて、細胞を含む支持体層に加圧送液して行われることを特徴とする[1]記載の3次元培養組織。
[3]培養液の送液が、支持体層の下部より行われることを特徴とする[2]記載の3次元培養組織。
[4]培養液の送液速度が、支持体1cm当たり0.1〜10μL/分であることを特徴とする[2]、[3]いずれか記載の3次元培養組織。
[5]細胞が、線維芽細胞である[1]〜[4]いずれか記載の3次元培養組織。
[6]支持体層がコラーゲンである[1]〜[5]いずれか記載の3次元培養組織。
[7]支持体層の下部及び側面が培養皿に接着していることを特徴とする[1]〜[6]いずれか記載の3次元培養組織。
[8][1]〜[7]いずれか記載の3次元培養組織を得るための培養方法及びその装置。
に関する。
That is, the present invention
[1] A three-dimensional culture tissue produced by perfusing a culture solution onto a support layer containing cells.
[2] The three-dimensional cultured tissue according to [1], wherein the perfusion of the culture solution is performed by feeding a pressurized solution to a support layer containing cells through a tube in which the culture solution is inserted into the support.
[3] The three-dimensional cultured tissue according to [2], wherein the culture solution is fed from below the support layer.
[4] The three-dimensional culture tissue according to any one of [2] and [3], wherein the culture solution feeding speed is 0.1 to 10 μL / min per cm 3 of the support.
[5] The three-dimensional cultured tissue according to any one of [1] to [4], wherein the cells are fibroblasts.
[6] The three-dimensional cultured tissue according to any one of [1] to [5], wherein the support layer is collagen.
[7] The three-dimensional cultured tissue according to any one of [1] to [6], wherein the lower and side surfaces of the support layer are adhered to the culture dish.
[8] A culture method and apparatus for obtaining the three-dimensional cultured tissue according to any one of [1] to [7].
About.

本発明の3次元培養組織は、細胞を含む支持体の水平方向の収縮を阻害することで細胞に生体と同じように張力を付加するとともに培養液を灌流させることにより、そこに含まれる細胞をインビボにより近い状態で維持することができる。   The three-dimensional cultured tissue of the present invention inhibits horizontal contraction of a support containing cells, thereby applying tension to the cells in the same manner as a living body and perfusing the culture solution, thereby It can be maintained closer to in vivo.

本法は、細胞とマトリックスが本来的に有する自己組織能にしたがって、生体内組織に類似の組織構築を促進させることを特色とする培養法である。つまり、従来法のような人工的な鋳型を使用せず、細胞自身による自然の組織構築能(self−assembly)を利用することから、生体内により近い組織形成となっていることが期待できる。   This method is a culture method characterized by promoting tissue construction similar to in vivo tissues according to the self-organizing ability inherently possessed by cells and matrices. That is, since a natural tissue-building ability (self-assembly) by the cell itself is used without using an artificial template as in the conventional method, it can be expected that the tissue formation is closer to that in the living body.

本発明の3次元培養組織の培養装置を示す図である。It is a figure which shows the culture apparatus of the three-dimensional culture tissue of this invention.

本発明の3次元培養組織は、細胞を含む支持体層に培養液を灌流させることを特徴とする。ここで、灌流とは、一般的には、人為的に臓器に血液を送ることをいうが、本発明では、人為的に管等を用いて、培養液を培養基質に送液することをいう。培養液の灌流は、プラスチック培養皿の培養表面に小穴を開け、その小穴に、送液ポンプに連結してある細いチューブを挿入することにより行われる。この培養皿に細胞を封入した支持体を作製後、ポンプを駆動させ新鮮培養液を支持体内に一定速度で加圧送液することにより、培養液は支持体内を底面から徐々に均一に広がり、支持体内全域を通過して支持体上面から支持体を離れる。このようにして、支持体内に分布している細胞に満遍なく緩慢な流速で移動する新鮮培養液を供給することができる。   The three-dimensional cultured tissue of the present invention is characterized in that a culture solution is perfused through a support layer containing cells. Here, perfusion generally refers to artificially sending blood to an organ, but in the present invention, artificially feeding a culture solution to a culture substrate using a tube or the like. . The culture medium is perfused by making a small hole in the culture surface of the plastic culture dish and inserting a thin tube connected to the liquid feeding pump into the small hole. After preparing the support body in which the cells are sealed in this culture dish, the pump is driven and the fresh culture solution is pressurized and fed into the support body at a constant speed, so that the culture solution gradually spreads uniformly from the bottom surface. It passes through the whole body and leaves the support from the upper surface of the support. In this way, a fresh culture solution that moves evenly at a slow flow rate can be supplied to cells distributed in the support.

インビボにおける支持体は、収縮とそれに反発する緊張が掛かった状態にある。収縮は細胞が周辺の支持体を足場として引き寄せることで起こる。緊張は、支持体が細胞による引力に反発することにより起こる。本発明では、この緊張を再現するために細胞に起因した支持体の収縮に任せるのではなく、支持体をプラスチック培養皿に接着させ、細胞を含む支持体の水平方向の収縮を阻害することにより、細胞に生体と同じように張力を付加し、インビボにより類似した細胞培養環境をつくることを特徴とする。プラスチック培養皿への支持体の接着性は、線維化コラーゲンコーティングを培養皿底部及び壁前面に対して行うことで高めることができる。また、培養皿底面内部に突出または傷を付けて支持体と培養皿が接する面積を増やし、繋留効率を上げることもできる。   The in vivo support is in a state of contraction and repulsive tension. Shrinkage occurs when the cells attract the surrounding support as a scaffold. Tension is caused by the support repelling the attractive forces by the cells. In the present invention, in order to reproduce this tension, it is not left to the contraction of the support caused by the cells, but by adhering the support to a plastic culture dish and inhibiting the horizontal contraction of the support containing cells. It is characterized by applying tension to cells in the same way as a living body to create a more similar cell culture environment in vivo. The adhesion of the support to the plastic culture dish can be enhanced by applying a fibrotic collagen coating to the bottom of the culture dish and the front of the wall. In addition, the tethering efficiency can be increased by increasing the area where the support and the culture dish are in contact by protruding or scratching the bottom of the culture dish.

本発明の3次元培養組織の支持体には、コラーゲン、ゼラチン、エラスチン、多糖類(ヒアルロン酸、コンドロイチン硫酸、キチン、キトサン等)、人工合成ポリマー(ポリ乳酸、ペプチド、ポリエステル類等)、フィブリン等を用いることができ、その性状としては、ゲル、スポンジ、シート等がある。   Examples of the support of the three-dimensional cultured tissue of the present invention include collagen, gelatin, elastin, polysaccharides (hyaluronic acid, chondroitin sulfate, chitin, chitosan, etc.), artificial synthetic polymers (polylactic acid, peptides, polyesters, etc.), fibrin, etc. The properties include gels, sponges, sheets and the like.

支持体の大きさ及び形は、特に限定されず、培養皿に合わせて作製することができるが、10〜100mmの円形培養皿に合わせて作製することが好ましく、35〜60mmの円形培養皿に合わせて作製することが特に好ましい。支持体を構築する成分の濃度も特に限定されないが、0.05〜5%が好ましく、0.1〜0.5%が特に好ましい。   The size and shape of the support are not particularly limited and can be prepared according to the culture dish. However, it is preferable that the support is prepared according to the circular culture dish of 10 to 100 mm. It is particularly preferable to produce them together. The concentration of the component constituting the support is not particularly limited, but is preferably 0.05 to 5%, and particularly preferably 0.1 to 0.5%.

本発明の3次元培養組織に用いられる細胞としては、例えば皮膚線維芽細胞、血管内皮細胞、リンパ内皮細胞、上皮細胞、色素細胞、脂肪細胞、神経細胞、肝臓星細胞、毛包細胞、網膜視細胞等が挙げられる。   Examples of cells used in the three-dimensional cultured tissue of the present invention include dermal fibroblasts, vascular endothelial cells, lymphatic endothelial cells, epithelial cells, pigment cells, fat cells, nerve cells, liver stellate cells, hair follicle cells, retinal vision. Examples thereof include cells.

細胞の密度及び分散状態は、特に限定されないが、1×10〜1×10個/mLの密度が好ましく、1×10〜2×10個/mLの密度が特に好ましい。また、均一に分散されていることが好ましい。 The density and dispersion state of the cells are not particularly limited, but a density of 1 × 10 3 to 1 × 10 7 cells / mL is preferable, and a density of 1 × 10 5 to 2 × 10 6 cells / mL is particularly preferable. Moreover, it is preferable that it is disperse | distributed uniformly.

培養皿に挿入したチューブは、プラスチック培養皿底面の厚みを利用して培養皿に固定する。挿入する送液用チューブの本数は、特に限定されないが、1〜10本が好ましい。送液用チューブを挿入する位置は、特に限定されないが、1本の場合は、プラスチック培養皿の培養表面中央が好ましく、複数の場合は、培養表面を均等にカバーできる位置が好ましい。送液用チューブの材質としては、フッ素樹脂、シリコンゴム、ポリイミド、ポリカーボネート、アクリル、プラスチック、ポリプロピレン、塩化ビニル樹脂等が挙げられる。その内径は、0.5〜2mmが好ましい。   The tube inserted into the culture dish is fixed to the culture dish using the thickness of the bottom surface of the plastic culture dish. The number of tubes for liquid feeding to be inserted is not particularly limited, but 1 to 10 is preferable. The position for inserting the liquid feeding tube is not particularly limited, but in the case of one, the center of the culture surface of the plastic culture dish is preferable, and in the case of a plurality, the position where the culture surface can be covered uniformly is preferable. Examples of the material for the liquid feeding tube include fluororesin, silicon rubber, polyimide, polycarbonate, acrylic, plastic, polypropylene, and vinyl chloride resin. The inner diameter is preferably 0.5 to 2 mm.

本発明の3次元培養組織に用いられる培養液は、特に限定されず、用いる細胞の培養に適した培養液及び添加物を利用することができる。例えば10%牛胎児血清を含むDulbecco’s Modified Eagle Medium(DMEM)等がある。   The culture solution used for the three-dimensional culture tissue of the present invention is not particularly limited, and a culture solution and an additive suitable for culturing the cells to be used can be used. For example, there is Dulbecco's Modified Eagle Medium (DMEM) containing 10% fetal bovine serum.

培養液の送液速度は、支持体1cm当たり0.1〜10μL/分が好ましく、特には、支持体1cm当たり1〜3μL/分が好ましい。 Feed rate of the culture, 0.1~10μL / min preferably per support 1 cm 3, in particular, 1~3μL / min is preferred per support 1 cm 3.

培養液の送液は、培養皿に挿入したチューブのもう一方の端にポンプを繋ぎ、そのポンプを稼動させることにより行う。ポンプとしては、シリンジ用ポンプ、点滴用ポンプ、血液循環用ポンプ、ペリスタポンプ、HPLC用ポンプ等を用いることができる。例えば、チューブのもう一方の端に培養液を注入したシリンジを繋ぎ、そのシリンジを送液ポンプに装着し、送液ポンプを稼動することにより培養液を送液することができる。この場合、用いるシリンジとしては、医療用のポリプロピレン製シリンジが好ましい。送液ポンプとしては、市販のシリンジ用ポンプを用いることができる。   The culture solution is fed by connecting a pump to the other end of the tube inserted in the culture dish and operating the pump. As the pump, a syringe pump, an infusion pump, a blood circulation pump, a peristaltic pump, an HPLC pump, or the like can be used. For example, the culture solution can be delivered by connecting a syringe into which the culture solution has been injected to the other end of the tube, attaching the syringe to the delivery pump, and operating the delivery pump. In this case, the syringe used is preferably a medical polypropylene syringe. A commercially available syringe pump can be used as the liquid feed pump.

支持体上面から支持体を離れた培養液の回収は、プラスチック培養皿の上部壁面に小穴を開け、チューブを挿入する。チューブの反対側の端をシリンジに接続しポンプで小穴の高さまで上昇した培養液を送液速度よりも遅い速度で吸引し回収する。または、培養皿よりも低い位置にチューブを垂らし、廃液用のタンクに接続し、高低差を利用して培養液の回収を行なう。チューブの素材としては、送液用チューブと同様のものを用いることができる。   To collect the culture solution that has left the support from the upper surface of the support, a small hole is made in the upper wall surface of the plastic culture dish, and a tube is inserted. The opposite end of the tube is connected to a syringe, and the culture solution that has been raised to the height of the small hole with a pump is sucked and collected at a rate slower than the feeding rate. Alternatively, the tube is hung at a position lower than the culture dish, connected to a waste tank, and the culture solution is collected using the height difference. As the material of the tube, the same material as the liquid feeding tube can be used.

本発明の3次元培養組織は、生体内組織に類似した性質を有しており、しかもその状態を維持して1ヶ月以上の長期間培養も可能である。したがって、生体内組織における細胞の本来的性質をインビトロで調べることが可能であり、生体内組織に対する被検物質の影響評価に用いることができる。医薬品や化粧品素材の生体内組織に対する安全性評価に用いることができる。また、医薬品や化粧品素材の生体組織内の特定の細胞機能に対する有効性評価に用いることができる。さらに、医薬品等の長期処理によって生じる慢性疾患のインビトロモデルとしても利用できる。   The three-dimensional cultured tissue of the present invention has properties similar to those of in vivo tissues, and can be cultured for a long period of one month or longer while maintaining this state. Therefore, it is possible to examine the intrinsic properties of cells in the in vivo tissue in vitro, and it can be used for evaluating the influence of the test substance on the in vivo tissue. It can be used for safety evaluation of pharmaceuticals and cosmetic materials against in vivo tissues. Further, it can be used for evaluating the effectiveness of a pharmaceutical or cosmetic material for a specific cell function in a living tissue. Furthermore, it can be used as an in vitro model of chronic diseases caused by long-term treatment of pharmaceuticals and the like.

本発明の3次元培養組織は、生体への移植用組織として用いることができる。移植用組織の用途としては、皮膚移植、毛包移植、肝臓移植等が挙げられる。   The three-dimensional cultured tissue of the present invention can be used as a tissue for transplantation into a living body. Examples of the use of the tissue for transplantation include skin transplantation, hair follicle transplantation, liver transplantation and the like.

本発明を詳細に説明するため、実施例として3次元培養組織の製造例及び実験例を挙げるが、本発明はこれに限定されるものではない。   In order to describe the present invention in detail, examples of production of a three-dimensional cultured tissue and experimental examples are given as examples, but the present invention is not limited thereto.

製造例1 培養液灌流方式3次元培養皮膚1の作製
図1に概略した方法で培養装置を作製した。直径2mmのドリルをアルコールランプで炙った。これを使用するプラスチック培養皿の底面中央に当て皿に垂直に立てて貫通させた。熱で柔らかくなったプラスチックが冷えて固まったらドリルを廻して皿に孔を開け、そこに60cm長のフッ素樹脂(PFA)チューブを差し込んだ。チューブの他端を5cm長のシリコンチューブと繋ぎ、シリコンチューブの他端はルアーフィッティング(サンプラテック、FTLL210−6)と繋いでパラフィルムで固定した。皿に差し込んだチューブは、エポキシ系接着剤(アラルダイトラピッド、ニチバン)で固定した。皿とチューブを繋いだままドラフト内に置き2時間程風乾した。エポキシ系接着剤が乾いた後、パラフィルム(Pechiney Plastic Packaging Company)で固定防水した。ルアーフィッティングにシリンジ(TERUMO 10mL)を繋ぎ70%エタノールで消毒した。DMEM(GIBCO)、10%(v/v)牛胎児血清、25mMのHEPES及び抗生物質(ペニシリン、ストレプトマイシン)をシリンジにて通液させた。
培養皿底部及び壁前面の線維化コラーゲンコーティングを行った。コーティングの方法は、クリーンベンチ内で、0.1%コラーゲン(I)をプラスチック培養皿に満杯に注ぎ、抜き取った。PBSをプラスチック培養皿に満杯に注ぎ、37℃の炭酸ガスインキュベータ内に1時間置いた後、PBSを取り除いた。クリーンベンチ内で、プラスチック培養皿の蓋を開けて、培養皿内部を乾燥させた。
0.6mLの5倍濃度のDMEM、0.3mLの牛胎児血清、0.9mLの滅菌水及び1.2mLの0.5%atelocollagen(IPC−50 KOKEN)を氷冷下にて混合しゾルを作製した。合計3mLのゾルを事前に遠心して沈殿させた皮膚線維芽細胞(6×105cells)に加えて細胞が均一になるまで懸濁し、細胞懸濁ゾル(細胞密度2×105cells/mL)3mLを培養装置の35mm培養皿に注いだ。37℃の炭酸ガスインキュベータ内にて2時間静置することによりゲル化させた。
ゲルよりも上部の培養皿壁面に、底面の場合と同様に穴を開け、60cm長のフッ素樹脂(PFA)チューブを孔に差し込み、チューブの端をパラフィルムで固定した。チューブの他端を5cm長のシリコンチューブ、ルアーフィッティング、シリンジの順に繋いだ。培養装置の培養皿の底面に接続してあるチューブの先に繋いだシリンジを送液ポンプ(アイシス社、CXF1020 ヒュージョン200)の架台に装着し、0.7μL/分の速度で送液した。同時に培養皿の壁面に接続してあるチューブの先に繋いだシリンジを別の送液ポンプの架台に装着し、送液よりも遅い速度で支持体上面の培養液を回収した。この方法で6日間培養した。
Production Example 1 Production of culture medium perfusion system three-dimensional cultured skin 1 A culture apparatus was produced by the method outlined in FIG. A drill with a diameter of 2 mm was beaten with an alcohol lamp. The plastic culture dish to be used was vertically penetrated from the center of the bottom of the plastic dish. When the plastic softened by heat had cooled and solidified, a drill was turned to make a hole in the dish, and a 60 cm long fluororesin (PFA) tube was inserted there. The other end of the tube was connected to a 5 cm long silicon tube, and the other end of the silicon tube was connected to a luer fitting (Samplertech, FTLL210-6) and fixed with parafilm. The tube inserted into the dish was fixed with an epoxy adhesive (Araldee Rapid, Nichiban). The plate and the tube were connected and placed in a fume hood and air dried for about 2 hours. After the epoxy adhesive was dried, it was fixed and waterproofed with parafilm (Pechiny Plastic Packaging Company). A syringe (TERUMO 10 mL) was connected to the luer fitting and disinfected with 70% ethanol. DMEM (GIBCO), 10% (v / v) fetal bovine serum, 25 mM HEPES and antibiotics (penicillin, streptomycin) were passed through a syringe.
Fibrous collagen coating was applied to the bottom of the culture dish and the front of the wall. In the coating method, 0.1% collagen (I) was poured into a plastic culture dish in a clean bench and extracted. PBS was poured into a plastic culture dish and placed in a 37 ° C. carbon dioxide incubator for 1 hour, and then the PBS was removed. In the clean bench, the lid of the plastic culture dish was opened to dry the inside of the culture dish.
0.6 mL of 5-fold concentrated DMEM, 0.3 mL of fetal bovine serum, 0.9 mL of sterilized water and 1.2 mL of 0.5% atelocollagen (IPC-50 KOKEN) were mixed under ice cooling to obtain a sol. Produced. A total of 3 mL of sol was added to dermal fibroblasts (6 × 10 5 cells) precipitated by centrifugation in advance and suspended until the cells became uniform, and cell suspension sol (cell density 2 × 10 5 cells / mL) 3 mL was poured into a 35 mm culture dish of the culture apparatus. Gelation was carried out by standing for 2 hours in a 37 ° C. carbon dioxide incubator.
A hole was made on the wall of the culture dish above the gel in the same manner as in the bottom, a 60 cm long fluororesin (PFA) tube was inserted into the hole, and the end of the tube was fixed with parafilm. The other end of the tube was connected in the order of a 5 cm long silicon tube, a luer fitting, and a syringe. A syringe connected to the tip of a tube connected to the bottom of the culture dish of the culture apparatus was mounted on a gantry of a liquid feed pump (Isis Co., Ltd., CXF1020 Fusion 200), and liquid was fed at a rate of 0.7 μL / min. At the same time, a syringe connected to the tip of a tube connected to the wall surface of the culture dish was attached to a stand of another liquid feeding pump, and the culture liquid on the upper surface of the support was collected at a slower speed than the liquid feeding. This method was cultured for 6 days.

製造例2 培養液灌流方式3次元培養皮膚2の作製
製造例1において、30日間培養したものを培養液灌流方式3次元培養皮膚2とした。
Production Example 2 Production of Culture Solution Perfusion Method 3D Culture Skin 2 In Production Example 1, the culture solution perfusion method 3D culture skin 2 was prepared for 30 days.

比較例1 従来の3次元培養皮膚1
製造例1において、10%牛胎児血清を含むDMEMを通液せず、培養皿内の培養液を1日1回交換したものを従来の3次元培養皮膚1とした。
Comparative Example 1 Conventional three-dimensional cultured skin 1
In Production Example 1, DMEM containing 10% fetal bovine serum was not passed, and the culture medium in the culture dish was replaced once a day to obtain a conventional three-dimensional cultured skin 1.

比較例2 従来の3次元培養皮膚2
製造例2において、10%牛胎児血清を含むDMEMを通液せず、培養皿内の培養液を1日1回交換したものを従来の3次元培養皮膚2とした。
Comparative Example 2 Conventional three-dimensional cultured skin 2
In Production Example 2, DMEM containing 10% fetal bovine serum was not passed, and the culture medium in the culture dish was changed once a day to obtain a conventional three-dimensional cultured skin 2.

実験例1 細胞突起数の測定
製造例1の培養液灌流方式3次元培養皮膚1内の皮膚線維芽細胞と比較例1の従来の3次元培養皮膚1内の皮膚線維芽細胞をゲルごと中性ホルマリン固定し、常法に従いパラフィン切片を作製後、HE染色した。その後、顕微鏡下で細胞1個当たりの細胞突起数を測定した。
Experimental Example 1 Measurement of the number of cell protrusions The culture solution perfusion method of Production Example 1 and the skin fibroblasts in the three-dimensional cultured skin 1 of Comparative Example 1 and the skin fibroblasts in the conventional three-dimensional cultured skin 1 of Comparative Example 1 are neutralized with the gel Formalin was fixed, paraffin sections were prepared according to a conventional method, and then stained with HE. Thereafter, the number of cell processes per cell was measured under a microscope.

実験結果を表1に示した。培養液灌流方式3次元培養皮膚1内の皮膚線維芽細胞では、従来の培養液を灌流しない3次元培養皮膚1内の皮膚線維芽細胞に比べ、より多くの細胞突起が認められた。生体内組織において、線維芽細胞は多数の突起を介しコラーゲン線維等のマトリックス成分と結合し、相互作用を及ぼしあっている。したがって、今回の結果は、培養液灌流方式3次元培養皮膚1内の皮膚線維芽細胞が生体内組織における細胞により近い状態にあることを示す。   The experimental results are shown in Table 1. Culture fluid perfusion method In the skin fibroblasts in the three-dimensional culture skin 1, more cell protrusions were observed compared to the skin fibroblasts in the three-dimensional culture skin 1 that was not perfused with the conventional culture fluid. In in vivo tissues, fibroblasts bind to and interact with matrix components such as collagen fibers through a number of processes. Therefore, this result shows that the skin fibroblasts in the culture medium perfusion system three-dimensional culture skin 1 are closer to the cells in the tissue in the living body.

Figure 2014113118
Figure 2014113118

実験例2 生細胞率の測定
製造例2の培養液灌流方式3次元培養皮膚2内の皮膚線維芽細胞と比較例2の従来の3次元培養皮膚2内の皮膚線維芽細胞をゲルごと中性ホルマリン固定し、常法に従いパラフィン切片を作製後、HE染色した。その後、顕微鏡下で生細胞と死細胞をカウントし、生細胞率を求めた。
Experimental Example 2 Measurement of Viable Cell Percentage of Cultured Perfusion Method in Production Example 2 Skin Fibroblasts in 3D Cultured Skin 2 and Skin Fibroblasts in Conventional 3D Cultured Skin 2 in Comparative Example 2 are Neutral with Gel Formalin was fixed, paraffin sections were prepared according to a conventional method, and then stained with HE. Thereafter, live cells and dead cells were counted under a microscope to determine the viable cell rate.

実験結果を表2に示した。培養液灌流方式3次元培養皮膚2内の皮膚線維芽細胞の生細胞率は、従来の培養液を灌流しない3次元培養皮膚2内のそれに比べ、高値を示した。生体内組織において、線維芽細胞は長期間生存する。したがって、今回の結果は、培養液灌流方式3次元培養皮膚2が生体内組織により近い状態にあることを示す。   The experimental results are shown in Table 2. Culture fluid perfusion method The viable cell rate of dermal fibroblasts in the three-dimensional culture skin 2 was higher than that in the conventional three-dimensional culture skin 2 where the culture solution was not perfused. In in vivo tissues, fibroblasts survive for a long time. Therefore, this result shows that the culture medium perfusion system three-dimensional cultured skin 2 is in a state closer to the in vivo tissue.

Figure 2014113118
Figure 2014113118

実験例3 コラーゲン及びヒアルロン酸生成能の測定
皮膚線維芽細胞におけるコラーゲン及びヒアルロン酸生成能を1型コラーゲン、3型コラーゲン及びヒアルロン酸合成酵素HAS−2のmRNA発現量を指標として測定した。すなわち、製造例1の培養液灌流方式3次元培養皮膚1及び比較例1の従来の3次元培養皮膚1のコラーゲンゲルをコラゲナーゼにより分解し、残った細胞から総RNAの抽出を行った。総RNAの抽出には、RNAiso Plus(タカラバイオ)及びRNeasy Mini Kit(QIAGEN)を用いた。抽出した総RNAを基にRT−PCR法により1型コラーゲン、3型コラーゲン及びHAS−2 mRNA発現量の測定を行った。RT−PCR法にはSuperScript III Platinum Two−Step qRT−PCR Kit with SYBR Green(インビトロジェン)を用いた。PCR反応は、95℃にて2分間初期変性を行った後、95℃:15秒、60℃:31秒を1サイクルとして40サイクル行った。内部標準としては、GAPDHを用いた。1型コラーゲン、3型コラーゲン及びHAS−2 mRNA発現量は、GAPDH mRNA発現量に対する割合として求めた。なお、測定に使用したプライマーは以下の通りである。
Experimental Example 3 Measurement of Collagen and Hyaluronic Acid Production Ability Collagen and hyaluronic acid production ability in dermal fibroblasts was measured using mRNA expression levels of type 1 collagen, type 3 collagen and hyaluronic acid synthase HAS-2 as an index. That is, the collagen gel of the culture solution perfusion system 3D cultured skin 1 of Production Example 1 and the conventional 3D cultured skin 1 of Comparative Example 1 was decomposed with collagenase, and total RNA was extracted from the remaining cells. For the extraction of total RNA, RNAiso Plus (Takara Bio) and RNeasy Mini Kit (QIAGEN) were used. Based on the extracted total RNA, the expression levels of type 1 collagen, type 3 collagen and HAS-2 mRNA were measured by RT-PCR. For the RT-PCR method, SuperScript III Platinum Two-Step qRT-PCR Kit with SYBR Green (Invitrogen) was used. The PCR reaction was initially denatured at 95 ° C. for 2 minutes, followed by 40 cycles of 95 ° C .: 15 seconds and 60 ° C .: 31 seconds. GAPDH was used as an internal standard. Type 1 collagen, type 3 collagen, and HAS-2 mRNA expression levels were determined as a percentage of the GAPDH mRNA expression level. In addition, the primer used for the measurement is as follows.

1型コラーゲン用のプライマーセット
AGGACAAGAGGCATGTCTGGTT(配列番号1)
TTGCAGTGGTAGGTGATGTTCTG(配列番号2)
Primer set AGGACAAGAGGGCATGTCTGGTT for type 1 collagen (SEQ ID NO: 1)
TTGCAGTGGGTAGGTGATGTCTG (SEQ ID NO: 2)

3型コラーゲン用のプライマーセット
TCCTTGCTGTGGTGGTGTTG(配列番号3)
GGCAAAACCGCCAGCTT(配列番号4)
Primer set TCCTTGCTGTGGTGGTGTTG for type 3 collagen (SEQ ID NO: 3)
GGCAAAACCGCCCAGCTT (SEQ ID NO: 4)

HAS−2用のプライマーセット
TGGATGACCTACGAAGCGATTA(配列番号5)
GCTGGATTACTGTGGCAATGAG(配列番号6)
Primer set TGGATGACCCTACGAAGCGATTA for HAS-2 (SEQ ID NO: 5)
GCTGGATTACTGTGGCAATGAG (SEQ ID NO: 6)

GAPDH用のプライマーセット
TGAACGGGAAGCTCACTGG(配列番号7)
TCCACCACCCTGTTGCTGTA(配列番号8)
Primer set TGAACGGGAAGCTCACTGG for GAPDH (SEQ ID NO: 7)
TCCACCACCCTGTTGCTTA (SEQ ID NO: 8)

実験結果を表3に示した。培養液灌流方式3次元培養皮膚1内の皮膚線維芽細胞では、従来の培養液を灌流しない3次元培養皮膚1内の皮膚線維芽細胞に比べ、1型コラーゲン、3型コラーゲン及びHAS−2 mRNA発現量の増加がみられた。生体内組織において、線維芽細胞はコラーゲンやヒアルロン酸合成酵素を生成し、細胞外マトリックスを構築している。したがって、今回の結果は、培養液灌流方式3次元培養皮膚1内の皮膚線維芽細胞が生体内組織における細胞により近い状態にあることを示す。   The experimental results are shown in Table 3. Culture fluid perfusion method The skin fibroblasts in the three-dimensional culture skin 1 are compared with the conventional type of skin fibroblasts in the three-dimensional culture skin 1 that is not perfused with the culture fluid, type 1 collagen, type 3 collagen and HAS-2 mRNA. Increased expression was observed. In in vivo tissues, fibroblasts produce collagen and hyaluronic acid synthase to construct an extracellular matrix. Therefore, this result shows that the skin fibroblasts in the culture medium perfusion system three-dimensional culture skin 1 are closer to the cells in the tissue in the living body.

Figure 2014113118
Figure 2014113118

本発明の細胞を含む支持体層に培養液を灌流させることを特徴とする3次元培養組織は、組織形態が生体に近いインビトロ培養組織である。この3次元培養組織は、化粧品素材や医薬品等の生体組織に及ぼす影響をインビトロにてより正確に評価するために利用できる。   The three-dimensional cultured tissue characterized in that a culture solution is perfused through a support layer containing cells of the present invention is an in vitro cultured tissue whose tissue form is close to that of a living body. This three-dimensional cultured tissue can be used for more accurately evaluating in vitro the influence of cosmetic materials, pharmaceuticals and the like on living tissues.

Claims (9)

細胞を含む支持体層に培養液を灌流させ製造することを特徴とする3次元培養組織。 A three-dimensional culture tissue produced by perfusing a culture solution on a support layer containing cells. 培養液の灌流が、培養液を支持体に挿入したチューブを通じて、細胞を含む支持体層に加圧送液して行われることを特徴とする請求項1記載の3次元培養組織。 The three-dimensional cultured tissue according to claim 1, wherein the perfusion of the culture solution is carried out by feeding under pressure to a support layer containing cells through a tube in which the culture solution is inserted into the support. 培養液の送液が、支持体層の下部より行われることを特徴とする請求項2記載の3次元培養組織。 The three-dimensional cultured tissue according to claim 2, wherein the culture solution is fed from a lower portion of the support layer. 培養液の送液速度が、支持体1cm当たり0.1〜10μL/分であることを特徴とする請求項2〜3いずれか記載の3次元培養組織。 The three-dimensional cultured tissue according to any one of claims 2 to 3 , wherein a feeding rate of the culture solution is 0.1 to 10 µL / min per 1 cm 3 of the support. 細胞が、線維芽細胞である請求項1〜4いずれか記載の3次元培養組織。 The three-dimensional cultured tissue according to any one of claims 1 to 4, wherein the cell is a fibroblast. 支持体層がコラーゲンである請求項1〜5いずれか記載の3次元培養組織。 The three-dimensional cultured tissue according to any one of claims 1 to 5, wherein the support layer is collagen. 支持体層の下部及び側面が培養皿に接着していることを特徴とする請求項1〜6いずれか記載の3次元培養組織。 The three-dimensional cultured tissue according to any one of claims 1 to 6, wherein the lower and side surfaces of the support layer are adhered to the culture dish. 支持体層を調製する培養皿が線維化コラーゲンコートされていることを特徴とする請求項1〜7いずれか記載の3次元培養組織。 The three-dimensional cultured tissue according to any one of claims 1 to 7, wherein the culture dish for preparing the support layer is coated with fibrotic collagen. 請求項1〜8いずれか記載の3次元培養組織を得るための装置。




The apparatus for obtaining the three-dimensional cultured tissue in any one of Claims 1-8.




JP2012270959A 2012-12-12 2012-12-12 A three-dimensional cultured tissue, wherein a culture solution is perfused through a support layer containing cells. Active JP6047000B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012270959A JP6047000B2 (en) 2012-12-12 2012-12-12 A three-dimensional cultured tissue, wherein a culture solution is perfused through a support layer containing cells.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012270959A JP6047000B2 (en) 2012-12-12 2012-12-12 A three-dimensional cultured tissue, wherein a culture solution is perfused through a support layer containing cells.

Publications (2)

Publication Number Publication Date
JP2014113118A true JP2014113118A (en) 2014-06-26
JP6047000B2 JP6047000B2 (en) 2016-12-21

Family

ID=51169834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012270959A Active JP6047000B2 (en) 2012-12-12 2012-12-12 A three-dimensional cultured tissue, wherein a culture solution is perfused through a support layer containing cells.

Country Status (1)

Country Link
JP (1) JP6047000B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107318505A (en) * 2017-07-14 2017-11-07 重庆市永川区兴旺食用菌有限公司 A kind of vegetables culture dish
WO2018147032A1 (en) 2017-02-09 2018-08-16 公立大学法人大阪府立大学 Fluidic chip for cell culture use, culture vessel, and culture method
US10597625B2 (en) 2016-10-20 2020-03-24 Takasago Electric, Inc. Perfusion culture apparatus and perfusion culture method
WO2024010064A1 (en) * 2022-07-08 2024-01-11 国立研究開発法人産業技術総合研究所 Cell culture apparatus and cell culture method

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102375692B1 (en) * 2020-02-27 2022-03-17 연세대학교 산학협력단 Culture apparatus that provides a haman-like environment including cell cultrue unit and culture system

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01120278A (en) * 1987-11-02 1989-05-12 Terumo Corp Method for cultivating cell and apparatus therefor
US20070178586A1 (en) * 2005-11-09 2007-08-02 The Ohio State University Research Foundation Methods and apparatuses for growing cells
WO2012036225A1 (en) * 2010-09-14 2012-03-22 学校法人 東京女子医科大学 Method for manufacturing multilayered cell sheet, multilayered cell sheet having vascular network obtained thereby, method of use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01120278A (en) * 1987-11-02 1989-05-12 Terumo Corp Method for cultivating cell and apparatus therefor
US20070178586A1 (en) * 2005-11-09 2007-08-02 The Ohio State University Research Foundation Methods and apparatuses for growing cells
WO2012036225A1 (en) * 2010-09-14 2012-03-22 学校法人 東京女子医科大学 Method for manufacturing multilayered cell sheet, multilayered cell sheet having vascular network obtained thereby, method of use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6016031918; Cell Transplantation Vol.7, 1998, p.319-326 *
JPN6016031919; J. Biomed. Mater. Res. Vol.56, 2001, p.368-375 *
JPN6016031921; Biomaterials Vol.27, 2006, p.5089-5098 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10597625B2 (en) 2016-10-20 2020-03-24 Takasago Electric, Inc. Perfusion culture apparatus and perfusion culture method
WO2018147032A1 (en) 2017-02-09 2018-08-16 公立大学法人大阪府立大学 Fluidic chip for cell culture use, culture vessel, and culture method
US11884905B2 (en) 2017-02-09 2024-01-30 University Public Corporation Osaka Fluidic chip for cell culture use, culture vessel, and culture method
CN107318505A (en) * 2017-07-14 2017-11-07 重庆市永川区兴旺食用菌有限公司 A kind of vegetables culture dish
CN107318505B (en) * 2017-07-14 2023-09-26 遵义师范学院 Vegetable culture dish
WO2024010064A1 (en) * 2022-07-08 2024-01-11 国立研究開発法人産業技術総合研究所 Cell culture apparatus and cell culture method

Also Published As

Publication number Publication date
JP6047000B2 (en) 2016-12-21

Similar Documents

Publication Publication Date Title
Madl et al. Engineering hydrogel microenvironments to recapitulate the stem cell niche
JP6047000B2 (en) A three-dimensional cultured tissue, wherein a culture solution is perfused through a support layer containing cells.
EP2639293B1 (en) Cell culture chamber, method for producing same, tissue model using cell culture chamber, and method for producing same
Raic et al. 3D models of the bone marrow in health and disease: yesterday, today, and tomorrow
JP6835384B1 (en) Cell culture device and its use
KR102102153B1 (en) A bead for cell encapsulation and culture based on decellularized tissue, and use thereof
Lee et al. Integration of microfluidic chip with biomimetic hydrogel for 3D controlling and monitoring of cell alignment and migration
NL2011895C2 (en) Fluidic device and perfusion system for in vitro tissue reconstruction.
US20210403850A1 (en) Semipermeable membrane and uses thereof
JPWO2016021498A1 (en) Method for producing fibrous protein material and cell culture method
Dutta et al. Effect of collagen nanofibers and silanization on the interaction of HaCaT keratinocytes and 3T3 fibroblasts with alumina nanopores
WO2005014774A1 (en) Carrier for culturing animal cell, and method for culturing or transplanting animal cell using said carrier for culture
CN107075443B (en) Three-dimensional cell culture system and cell culture method using the same
JP2021516542A (en) Exobibo subcutaneous injection model
Minuth et al. Tissue factory: conceptual design of a modular system for the in vitro generation of functional tissues
US20210230526A1 (en) Cell enclosure device and use for same
CN103898055A (en) Establishment method of in-vitro cell culture platform with different matrix hardnesses
Abuwatfa et al. Scaffold-based 3D cell culture models in cancer research
JP6425420B2 (en) Cell culture chamber and method for producing the same, cell culture method using cell culture chamber and cell culture kit
Xu et al. Engineered Artificial Skins: Current Construction Strategies and Applications
WO2013120613A1 (en) Micro fluidic system for simulating in vivo-equivalent cell barriers
Bolanta et al. Synthesis of Poly (acrylic acid)-Cysteine-Based Hydrogels with Highly Customizable Mechanical Properties for Advanced Cell Culture Applications
Kistamás et al. Multifactorial approaches to enhance maturation of human iPSC-derived cardiomyocytes
Takezawa et al. Mass transport via naturally branched scaffolds maintains viability of a reconstituted model of connective tissue
Verhulsel In vitro reproduction of a gut on a microfluidic chip

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151021

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160823

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161018

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20161115

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20161118

R150 Certificate of patent or registration of utility model

Ref document number: 6047000

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250